Browsing by Subject "Immunocompromised patients"
Now showing items 1-2 of 2
-
(Sociedad Chilena de Infectología, 2018)Background: There is no consensus on the optimal dosage use of posaconazole (PSC) for invasive fungal infection (IFI) in pediatric patients and normally it is adjusted with drug levels (DLs) >= 0.7 mu g/ml and >= 1.25 mu ...
-
(Sociedad Chilena de Infectologia, 2018)© 2018, Sociedad Chilena de Infectologia. All rights reserved.Background: There is no consensus on the optimal dosage use of posaconazole (PSC) for invasive fungal infection (IFI) in pediatric patients and normally it is ...